BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25758277)

  • 1. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period.
    Zhou HJ; Yan Y; Zhou B; Lan TF; Wang XY; Li CS
    Chin Med J (Engl); 2015 Mar; 128(6):804-10. PubMed ID: 25758277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal fibrosis in 27 Korean patients: single center experience.
    Ha YJ; Jung SJ; Lee KH; Lee SW; Lee SK; Park YB
    J Korean Med Sci; 2011 Aug; 26(8):985-90. PubMed ID: 21860546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis.
    Duchene DA; Winfield HN; Cadeddu JA; Clayman RV; Gomella LG; Kavoussi LR; Mikhail AA; Park S; Permpongkosol S; Shalhav AL
    Urology; 2007 Jun; 69(6):1017-21. PubMed ID: 17572177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics of IgG4 related retroperitoneal fibrosis: a report of 5 cases and literature review].
    Dun YJ; Yu LP; Du YQ; Sheng ZZ; Wang GW; Li X; Yang B; Xu T; Huang XB; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):622-7. PubMed ID: 26284398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of retroperitoneal fibrosis: report of 26 cases].
    Cai L; Zhou LQ; He ZS; Li NC; Pan BN
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):749-51. PubMed ID: 18953929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
    Lian L; Wang C; Tian JL
    Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcomes in primary and secondary retroperitoneal fibrosis].
    Heidenreich A; Derakhshani P; Neubauer S; Krug B
    Urologe A; 2000 Mar; 39(2):141-8. PubMed ID: 10768224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases.
    O'Brien T; Fernando A
    BJU Int; 2017 Oct; 120(4):556-561. PubMed ID: 28502080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
    Koo BS; Koh YW; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
    Mod Rheumatol; 2015 Mar; 25(2):194-8. PubMed ID: 25036229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
    Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH
    Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.
    Wang K; Wang Z; Zeng Q; Zhu L; Gao J; Wang Z; Zhang S; Yang F; Shen D; Wang Y; Liu Y
    PLoS One; 2021; 16(2):e0245601. PubMed ID: 33600452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and prognostic analysis of retroperitoneal fibrosis in 32 patients].
    An LM; Xu YF; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):265-9. PubMed ID: 22517001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.
    Moroni G; Gallelli B; Banfi G; Sandri S; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2006 Sep; 21(9):2485-90. PubMed ID: 16702201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and postoperative retroperitoneal fibrosis-experience with 18 cases.
    Katz R; Golijanin D; Pode D; Shapiro A
    Urology; 2002 Nov; 60(5):780-3. PubMed ID: 12429295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis.
    Brandt AS; Kamper L; Kukuk S; Haage P; Roth S
    Urol Int; 2014; 93(3):320-5. PubMed ID: 25073896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic treatment of retroperitoneal fibrosis.
    Fugita OE; Jarrett TW; Kavoussi P; Kavoussi LR
    J Endourol; 2002 Oct; 16(8):571-4. PubMed ID: 12470464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmesocolic ureteral intraperitonealization: a new approach for laparoscopic treatment of retroperitoneal fibrosis.
    Tobias-Machado M; Correa WF; Korkes F; Juliano C; Muller S; Pompeo AC
    J Laparoendosc Adv Surg Tech A; 2011 May; 21(4):341-4. PubMed ID: 21486153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.
    Khosroshahi A; Carruthers MN; Stone JH; Shinagare S; Sainani N; Hasserjian RP; Deshpande V
    Medicine (Baltimore); 2013 Mar; 92(2):82-91. PubMed ID: 23429355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Laparoscopic and Open Ureterolysis for Retroperitoneal Fibrosis: Results from a Tertiary Referral Center.
    Ilki FY; Bulbul E; Gultekin MH; Citgez S; Demirdag C; Ozden SB; Onal B
    J Endourol; 2022 Nov; 36(11):1425-1430. PubMed ID: 35521656
    [No Abstract]   [Full Text] [Related]  

  • 20. Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a single-center experience.
    Arvind NK; Singh O; Ali Q; Singh J; Gupta SS; Sahay S
    J Laparoendosc Adv Surg Tech A; 2014 Mar; 24(3):159-64. PubMed ID: 24479819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.